Robotic eye surgery for vitreoretinal conditions
Part of Eyes & vision clinical trials.
This study tests a robotic system to assist eye surgery for certain retina and vitreous conditions, such as bleeding in the eye or a wrinkle on the macula. It aims to see if the robot can safely help improve vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old
- You need eye surgery for conditions like bleeding in the vitreous (diabetic retinopathy, vascular occlusion, or due to blood thinners) or a macular pucker
- You have an artificial lens in the eye or had your natural lens removed
- Your best corrected vision is less than 7/10 (not fully clear)
- You are healthy enough to undergo anesthesia and are considered fit for robotic surgery by your surgeon
- You have health insurance
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new robot-assisted surgical technique for doing a full-thickness corneal transplant. The goal is to see if the robot can help make the surgery more precise and safer.
This trial tests whether a specific eye surgery plus targeted clot-busting medicine and gas can improve vision after bleeding under the retina from “wet” age-related macular degeneration. It aims to reduce how long the bleeding lasts and help protect the central vision.
This trial tests whether a special eye scan (OCT) can help guide eye surgery during the operation. It may improve how surgeons see and target the exact eye structures they need to treat.
This study tests whether a futuristic headset that projects digital information can help surgeons see better during eye surgery. You may be able to participate if you are having a standard eye procedure and have no other eye problems that could make surgery riskier.
This study tests a new robotic device that uses light scans (OCT) to look at the front part of your eye. It may help find problems like redness or a foreign body without needing traditional exams.
This Phase 2 study tests OpRegen, a treatment delivered during special eye surgery, for geographic atrophy related to age-related macular degeneration (GA from AMD). It also includes an imaging “substudy” that uses detailed pictures of your retina to better track safety and activity.
Hear when a new Vitreoretinal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.